Cytokinetics financials

WebFeb 6, 2014 · Financial Guidance 2014. Cytokinetics also announced its financial guidance for 2014. The company anticipates cash revenue will be in the range of $19 to $21 million, cash R&D expenses will be in ...

Cytokinetics Stock: Emerging Leader In Heart Failure Drugs

WebApr 12, 2024 · Finally, Truist Financial assumed coverage on Cytokinetics in a report on Tuesday, December 20th. They issued a “buy” rating and a $60.00 price target for the company. One research analyst has ... WebNov 3, 2024 · SOUTH SAN FRANCISCO, Calif., Nov. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the third quarter of 2024. Net loss for the third quarter was $76.1 million, or $0.95 per share, compared to net loss for the third quarter of 2024 of $3.2 million, or $0.05 per share. northgate gmc dealership https://pascooil.com

SEC FILINGS Cytokinetics, Inc.

WebApr 11, 2024 · Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 33.36 -0.27 (-0.80%) At close: 04:00PM EDT 33.36 0.00 (0.00%) After hours: 04:11PM EDT Time... WebApr 2, 2024 · Financials In 2024, Cytokinetics reported revenues of $2.0 million for Q4 and $94.6 million for the full year, compared to $55.6 million and $70.4 million in the same … WebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% … northgate gm

Cytokinetics To Participate In The 22nd Annual Needham Virtual ...

Category:Cytokinetics Reports Second Quarter 2024 Financial Results

Tags:Cytokinetics financials

Cytokinetics financials

Cytokinetics (CYTK) Dips 20% so Far in 2024 on Setbacks

WebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity. Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate WebCYTK Finanicals Stock Screener Earnings Calendar Sectors Nasdaq CYTK U.S.: Nasdaq Cytokinetics Inc. Watch list Create CYTK Alert After Hours Last Updated: Mar 8, 2024 7:23 p.m. EST Delayed...

Cytokinetics financials

Did you know?

WebMar 1, 2024 · SOUTH SAN FRANCISCO, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the fourth quarter and full year 2024. Net loss for the fourth quarter was $137.4 million or $1.45 per share and the net loss for the year 2024 was $389.0 million or $4.33 per share. Web2 days ago · Cytokinetics, Incorporated (CYTK) 45.71 +1.58 (3.58%) Feb 17, 2024, 4:00 PM EST - Market closed Overview Financials Statistics Forecast Dividends Profile Chart …

Web18 hours ago · Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 04/03/23-4:00PM EST GlobeNewswire 3 Best Stocks to Buy Now, 4/3/2024, According to Top Analysts WebApr 10, 2024 · Forward-looking statements are not guarantees of future performance, and Cytokinetics' actual results of operations, financial condition and liquidity, and the …

WebDescription. Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … WebMar 1, 2024 · SOUTH SAN FRANCISCO, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, ... Financials. Revenues for the three and twelve months ended December 31, 2024 were $2.0 million and $94.6 million ...

WebApr 10, 2024 · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. About the company Rewards Revenue is forecast to grow 46.65% per year Risk Analysis Negative shareholders equity

WebFind real-time CYTK - Cytokinetics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Financials. Next reporting date: May 11, 2024: EPS forecast (this quarter) northgate gonzalez market corporate officeWebCytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate muscle function for the … northgate gonzalez grocery stores ownersWebMar 24, 2024 · CYTOKINETICS, INCORPORATED : Forcasts, revenue, earnings, analysts expectations, ratios for CYTOKINETICS, INCORPORATED Stock CYTK US23282W6057 how to say come in dog languageWebApr 6, 2024 · CYTK Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. northgate golf courseWebNov 3, 2024 · Enrollment Complete in Cohort 3 of REDWOOD-HCM; Results Expected in Q1 2024. SOUTH SAN FRANCISCO, Calif., Nov. 03, 2024 (GLOBE NEWSWIRE) -- … northgate golf clubWebCYTK Cytokinetics Inc. Annual Income Statement - WSJ Subscribe Sign In Cytokinetics Inc. CYTK (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 03/28/23 $34.98 … northgate golfWebApr 5, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media. Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. northgate gonzalez market hours